Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
Nature Communications
|
March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasis
Anna Lorentzen, Paul F Becker, Jan Kosla, et al.
Cell Metabolism
|
September 20, 2016
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand, Katrin Singer, Gudrun E Koehl, et al.
Nature Medicine
|
December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
British Journal of Cancer
|
December 26, 2022
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
Alexander Scheiter, Frederik Hierl, Florian Lüke, et al.
Nature Communications
|
January 15, 2024
Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma
Tirtha Chanda, Katja Hauser, Sarah Hobelsberger, et al.
Nature Medicine
|
June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2023
Treatment management for <i>BRAF</i>-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Maximilian Haist, Henner Stege, Friederike Rogall, et al.
Cancers
|
July 20, 2021
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2025
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients
Selma Ugurel, Nessr Abu Rached, Thilo Gambichler, et al.
BMC Medicine
|
January 13, 2026
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Alexander Scheiter, Simon Mellin, Felix Keil, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
Nature Communications
|
March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasis
Anna Lorentzen, Paul F Becker, Jan Kosla, et al.
Cell Metabolism
|
September 20, 2016
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Almut Brand, Katrin Singer, Gudrun E Koehl, et al.
Nature Medicine
|
December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
British Journal of Cancer
|
December 26, 2022
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
Alexander Scheiter, Frederik Hierl, Florian Lüke, et al.
Nature Communications
|
January 15, 2024
Dermatologist-like explainable AI enhances trust and confidence in diagnosing melanoma
Tirtha Chanda, Katja Hauser, Sarah Hobelsberger, et al.
Nature Medicine
|
June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2023
Treatment management for <i>BRAF</i>-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Maximilian Haist, Henner Stege, Friederike Rogall, et al.
Cancers
|
July 20, 2021
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2025
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients
Selma Ugurel, Nessr Abu Rached, Thilo Gambichler, et al.
BMC Medicine
|
January 13, 2026
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Alexander Scheiter, Simon Mellin, Felix Keil, et al.
Page
of 15